Zoetis
ZTS
$158.52
Share price
3.36%
Change (1 day)
-8.38%
Change (1 year)
Categories
P/S ratio for Zoetis (ZTS)
P/S ratio as of April 2024 (TTM): 8.42
According to Zoetis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.42122. At the end of 2023 the company had a P/S ratio of 10.6.
P/S ratio history for Zoetis from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.6 | 25.46% |
| 2022 | 8.45 | -43.07% |
| 2021 | 14.8 | 26% |
| 2020 | 11.8 | 17.21% |
| 2019 | 10.1 | 42.76% |
| 2018 | 7.04 | 6.47% |
| 2017 | 6.61 | 22.31% |
| 2016 | 5.41 | 8.12% |
| 2015 | 5.00 | 10.96% |
| 2014 | 4.51 | 25.8% |
| 2013 | 3.58 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.45 | -70.85% | 🇺🇸 USA |
 Eli Lilly LLY | 20.5 | 142.99% | 🇺🇸 USA |
 Sanofi SNY | 2.41 | -71.39% | 🇫🇷 France |
 Merck MRK | 5.52 | -34.40% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | 0.5213 | -93.81% | 🇺🇸 USA |
 Kindred Biosciences
KIN | N/A | N/A | 🇺🇸 USA |
 Heska Corporation
HSKA | 5.14 | -38.99% | 🇺🇸 USA |